Your session is about to expire
← Back to Search
Carbon Dioxide for Stroke in Children (COMIC Trial)
COMIC Trial Summary
This trial will help researchers learn more about how changes in blood flow and metabolism influence brain development.
COMIC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOMIC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMIC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have sickle cell disease (Hb SS) or Sβ-thalassemia.I sometimes have headaches but don't take daily medication for them.I am not taking any medication that widens my blood vessels.I have never had epilepsy.I am between 3 and 50 years old and healthy.I am between 3 and 50 years old.You have been connected to a machine called ECMO in the past.I can undergo an MRI scan without needing to be sedated.I have never had a stroke or brain blood vessel issues.
- Group 1: Healthy Controls
- Group 2: Extracorporeal Membrane Oxygenation survivors
- Group 3: Sickle Cell Anemia participants
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment enrolling individuals over 40 years of age?
"The minimum age requirement for this clinical trial is 3 years, while the upper limit of participants' ages cannot exceed 50."
Is it possible for me to join this experiment?
"This trial seeks out 350 patients affected by stroke, ranging from 3 years old to 50. Participants must have a clean mental health record and be healthy enough for an MRI scan without sedation; they can suffer occasional headaches if not taking preventative medicine. Additionally, those enrolling cannot have ever had epilepsy or cerebrovascular disease, nor should they be on vasodilatory medications such as sildenafil or verapamil. Lastly, all applicants are required to possess either the Hb SS form of thalassemia or SBeta-thal genotype."
To what extent is the current clinical trial taking on participants?
"Affirmative. Clinicaltrials.gov's repository of data confirms that this research, which was first listed on October 17th 2019, is actively recruiting participants. 350 people need to be selected from a single clinical site."
Are there any available positions in this research endeavor for participants?
"According to clinicaltrials.gov, this medical trial is currently seeking patients for participation. This study was initially launched on October 17th 2019 and most recently edited on November 8 2021."
Share this study with friends
Copy Link
Messenger